Navigation Links
Taha-Burchiel REK

ProductsTaha-Burchiel REK
Company Integra Radionics, Inc.
Item Taha-Burchiel REK
Features Telescoping cannula to reduce mechanical damage. Specialized sterilization tray to prevent tip damage. Complete support of functional neurosurgery through one cannula.
Description Taha-Burchiel REK, An Precise placement integrated with the CRW system for simplified functional neurosurgery. The REK was developed in conjunction with Dr. Jamal Taha and Dr. Kim Burchiel at the University of Cincinnati. The unique back-loading design of the recording electrode helps prevent tip damage upon insertion into the brain. Electrodes are calibrated to target depth and held inside the cannula by an ergonomic spacer that doubles as a handle for insertion. The passing cannula of the kit allows for implantation of a deep brain stimulating electrode.
Info Integra Radionics, Inc.
Customer Service: 1-800-466-6814
Web site: http://www.radionics.com/

Related medicine products :

1. Elmed Hand Activated Monopolar Forceps
2. Bipolar Hand Activated Forceps
3. Bipolar Foot Activated Forceps
4. European Bipolar Foot Activated Forceps
5. Titanium Foot Activated Forceps
6. The Quest ACTester Activated Clotting Time System
7. Activated Protein C Resistance
8. Plasminogen Activator Inhibitor 1, Activity
9. Tissue Plasminogen Activator, Antigen
10. VISULAS 690s Photodynamic Therapy Laser System
11. VNS Therapy System
(Date:12/3/2008)...ewswire-FirstCall/ -- Forest Laboratories, Inc. (N...fied of an unsolicited mini-tender offer by TRC Ca...ate investment company. Forest Laboratories has r...to 3.0 million outstanding shares of the company,s...nt of its outstanding shares. The offer price of ...
(Date:12/3/2008)... 3 MAP,Pharmaceuticals,...ompany, will,participate in a panel discussion ti...t Conditions" at the 2008 RBC Capital Markets Heal..., at 10:00 am (ET) in New York City. , A li...le on the Investor,Relations section of MAP Pharm...
(Date:12/3/2008)...ellastim, an animal-free recombinant albumin produ... and human derived serum in CHO cell culture. , ...cember 3, 2008 -- Cellastim has proven to be a rob...edia and can improve both the growth kinetics and ... chemically defined media. , , ,Studies support In...
(Date:12/3/2008)... As previously announced,...ned subsidiary, WebMD Health Corp. (Nasdaq: WBMD...holders beginning at 9:30 a.m. Eastern Time on Wed...io webcast of the meetings will be available over ...e meetings, investors can go to www.hlth.com (in...
Breaking Medicine News(10 mins):Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2Health News:HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders 2
...a medication commonly prescribed to alleviate symp... effective than a placebo, according to a study// ... Center. “There was no benefit at all, and there ...ys lead author Thomas Neylan, MD, medical director...
...child with an eating disorder - monitoring meals, ...ut two new studies from researchers at the Stanfor...rd Children's Hospital indicate a need for increas... adolescents with the condition, and pre-teen weig...
...ho once treated mainly elderly patients for health...ke are seeing increasingly// younger patients who ...issue of Mayo Clinic Proceedings focuses on the in...ome, a state characterized by cardiovascular risk ...
...dertake a long-term weight training program produc...ng that allows physiologists //to understand why w...metabolic function. A study published in the Dece...Physiology-Endocrinology and Metabolism looked at ...
Other Medicine News:Health News:Common PTSD Drug is No More Effective Than Placebo 2Health News:Study Focus on the Need for Vigilance in Two Key Areas Among Adolescents 2Health News:Study Focus on the Need for Vigilance in Two Key Areas Among Adolescents 3Health News:Treating Obesity Vital for Public Health, Physicians Say 2Health News:Varying Weight Training Intensity Ups Growth Hormone in Women 2
(Date:12/2/2008)...izon Therapeutics, Inc., a,privately held biophar...al,Phase 3 trials evaluating its lead investigati...endpoints. HZT-501, a novel, proprietary fixed-dos...motidine, demonstrated a,statistically significan...i-inflammatory drug (NSAID)-induced upper gastroin...
(Date:12/1/2008)...-- New research has found that the availability of...canner in an emergency room can significantly incr...tentially life-saving treatment. Results of the st...)-Salem Hospital in Salem, Mass., will be presente...Society of North America (RSNA). , , "The h...
(Date:12/1/2008)...Call/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VND...e world,s leading medical journals, results of cli...erimental compound tasimelteon (VEC-162). The pub...onin agonist tasimelteon (VEC-162) for transient i...trolled multicentre trials." Results are reported ...
(Date:12/1/2008)...Pte Ltd today announced the initiation of a Phase ...active JAK2 inhibitor, in leading medical centers ...myelofibrosis (CIMF). , , The trial is des...B1518 in patients with CIMF and is expected to enr...dy will assess the safety profile and evaluate the...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3George to receive Pulp Biology and Regeneration Award 22800 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 2Best Practice Database Adds Research on New Product Commercialization 22793 1Best Practice Database Adds Research on New Product Commercialization 22793 2ADHD Gene Doesnt Predict Response to Drugs 22791 1ADHD Gene Doesnt Predict Response to Drugs 22791 2ADHD Gene Doesnt Predict Response to Drugs 22791 3
...ercentage of Working Age People with Diabetes, Hos...and National Averages, PITTSBURGH, April 02, 2007 ...Group on Health (PBGH) announced today the,release...ity of,care for people with Type 2 diabetes. The i...6 presents an overview of patient,demographics, ho...
...hed in Vaccine Shows Strong Immune Response, Prote...., April 02, 2007 /PRNewswire-FirstCall/ -- Novava...red a robust immune,response and provided protecti...ording to pre- clinical data published in the onli...cine was tested in three animal models, including,...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 2Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 3Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 4